2016
DOI: 10.1016/j.msec.2016.06.058
|View full text |Cite
|
Sign up to set email alerts
|

Cyclodextrin-polyhydrazine degradable gels for hydrophobic drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
26
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 36 publications
(28 citation statements)
references
References 58 publications
(49 reference statements)
2
26
0
Order By: Relevance
“…As previously reported, the swelling index depends on the nature of the polymer, the average molecular weight, the rigidity of the polymer chain, the degree of crosslinking, and the network mesh size as well as external conditions, such as pH and temperature. 29,30 Moreover, the swelling index observed could be related with the absorption mechanism, which is determined by the diffusion process of water into the pores of hydrogel. 31 Furthermore, different swelling capacities were evaluated according to the pH of the solutions, as depicted in Figure 4.…”
Section: Molecular Dynamics Simulation Resultsmentioning
confidence: 99%
“…As previously reported, the swelling index depends on the nature of the polymer, the average molecular weight, the rigidity of the polymer chain, the degree of crosslinking, and the network mesh size as well as external conditions, such as pH and temperature. 29,30 Moreover, the swelling index observed could be related with the absorption mechanism, which is determined by the diffusion process of water into the pores of hydrogel. 31 Furthermore, different swelling capacities were evaluated according to the pH of the solutions, as depicted in Figure 4.…”
Section: Molecular Dynamics Simulation Resultsmentioning
confidence: 99%
“…bCDs are being widely employed as solubilizing agent for poorly water‐soluble drugs and to enhance the bioavailability of class II and IV compounds of the Biopharmaceutical Classification System (BSC), thanks to the unique capability to form stable complexes in aqueous media through “host–guest” inclusion phenomena . The use of bCDs in pharmaceutics has been extended also for class I and III BSC compounds, especially for treatments requiring prolonged and controlled release profiles, as in the case of antimicrobial and antibiotic treatments .…”
Section: Resultsmentioning
confidence: 99%
“…Synthesis of mono (6-amino-6-deoxy)-β-CD, CD functionalized alginate and methacrylated gelatin 2.3.1. Mono (6-amino-6-deoxy)-β-CD or EDA-β-CD EDA-β-CD was synthesized through a two-step reaction according to the reported procedure (Jalalvandi et al, 2016;Jalalvandi et al, 2017). First, a monotosyl derivative of β-CD was prepared by the reaction of ptoluene sulfonyl chloride with β-CD in water.…”
Section: Instrumentationmentioning
confidence: 99%
“…Of various types of crosslinking methods, injectable hydrogels are particularly interesting for clinical use. These hydrogels are applied through a syring and undergo a sol-gel transition at the site of injection where they can fit the geometry of target site, through a minimally invasive procedure (Jalalvandi et al, 2016).…”
Section: Introductionmentioning
confidence: 99%